Nucleome Therapeutics
Nucleome Therapeutics technology uses novel molecular biology techniques that define the 3D structure of the genome and computational genomics powered by machine learning to help deliver the next generation of genetically guided therapeutics.
Also Known As
Nucleome
AngelList URL
B2X
Company Operating Status
Active
Country
Crunchbase URL
Date Incorporated
July 17, 2019
Founded Date
July 17, 2019
Full Address
Bioescalator Innovation Building, University Of Oxford Old Road Campus, Roosevelt Dr, Oxford, United Kingdom, OX3 7FZ
Funded Company
Funding Round Date
October 1, 2022
Funding Round Amount (USD)
44,000,000
Headquarters
Incorporation Reference
12109297
Latest Funding Round Date
October 19, 2022
Latest Funding Round Amount (USD)
42,350,000
Latest Funding Type
Legal classification
LinkedIn URL
Location
Number of Employees (Ranges)
1 – 10
Pitchbook URL
Total Funding Amount (USD)
86,350,000
Twitter URL
UKSIC Code
72110
Official Website
Wellfound ID
Find more companies like Nucleome Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.